Privacy

We use cookies on our website. Some of them are essential, while others help us improve this website and your experience.
In this overview you can select and deselect individual cookies of a category or entire categories. You will also receive further information about the available cookies.
group essential
name Netzhirsch
technical name _netzhirsch_cookie_opt_in
provider
expire in days 30
privacy policy
use Used to determine which cookie has been accepted or rejected.
allowed
group essential
name Contao CSRF Token
technical name csrf_contao_csrf_token
provider
expire in days 0
privacy policy
use Protects the website against counterfeiting of cross-location requests. After closing the browser, the cookie will be deleted again.
allowed
group essential
name PHP SESSION ID
technical name PHPSESSID
provider
expire in days 0
privacy policy
use PHP cookie (programming language), PHP data identifier. Only contains a reference to the current session. No information is stored in the user's browser and the cookie can only be used by the current website. This cookie is mainly used in forms to increase user friendliness. Data entered in forms are e.g. briefly saved when there is an input error by the user and the user receives an error message. Otherwise all data would have to be entered again.
allowed
group Analytics
name Google Analytics
technical name _ga, _gat, _gid
provider Google LLC
expire in days 730
privacy policy https://policies.google.com/privacy
use Google cookie for website analysis. Generates anonymous statistical data about user behavior when browsing on the website.
allowed
group Vimeo
name Vimeo
technical name _gid,_gac_UA-76641-8,_gcl_au,_gcl_aw,_gcl_dc ,_fbp,continuous_play_v3,_abexps,player,__qca, vimeo_gdpr_optin,embed_preferences, search_click_position,sd_client_id,_ga,vuid,__ssid
provider Vimeo Inc
expire in days 3590
privacy policy https://vimeo.com/cookie_policy
use Allows you to use the Vimeo video player.
allowed
group Analytics
name Matomo
technical name _pk_ses.4.[domainHash], _pk_id.4.[domainHash]
provider Matomo
expire in days 390
privacy policy https://www.biofluidix.com/contact/privacy.html
use Matomo cookie used for website analysis, ad targeting and ad measurement.
allowed
group essential
name Contao HTTPS CSRF Token
technical name csrf_https-contao_csrf_token
provider
expire in days 0
privacy policy
use Dient zum Schutz der Website vor Fälschungen von standortübergreifenden Anfragen . Nach dem Schließen des Browsers wird das Cookie wieder gelöscht
allowed

Innovation & Research

The participation in publicly funded research projects allows us to contribute to the investigation and development of novel technological approaches to deliver small volumes of liquids of any kind and any rheology. Our scientific background in combination with our engineering expertise result in precise and reliable solutions, driving the low volume dispensing market to unprecedented possibilities.

3D-Bio-Net

The 3D Bio-Net is a collaboration project to establish an advanced 3D Bio-Printing platform in the network of small and medium-sized enterprises (KMU).

As part of the overall project, Biofluidix is engaged in the research of dosing technologies for 3D bio-printing and the realization of a 3D-BioPrinter with sterilizable dosing components. The aim of the sub-project is to provide a device that is equipped with innovative, sterilizable dosing technology based on disposable components and can be used for the research work of the partners. At the end of the project, a functional, experimentally characterized demonstrator with associated 3D bio-printing processes will be presented to the public.

3D-TuMo Print

Bio-printable 3D in vitro tumor-tissue-model for high throughput testing of tumor therapeutics.

Project description
The number of cancer patients is increasing steadily. This fact expresses the urgent need of understanding the origin of tumors and drives the development of novel treatment methods. Since the development of new tumor-therapeutic substances is highly time-consuming and costly, an affordable alternative is desired for the future. This can be achieved by earlier identification of relevant drug candidates and better prediction of their efficacy. Therefore, it is necessary to use a suitable in vitro substitute, like a 3D-tumor-tissue model, for an early testing. The aim of the project 3D TuMoPrint is to establish a high-throughput testing system for tumor therapeutics based on a 3D-organotypic-tumor-tissue model in biomimetic hydrogels for the production in a bio-printer workstation. Apart from the model production, the system should have an integrated microscopic control to simplify the analysis of the models.

Project duration
15.01.2019 - 15.01.2021

Project partners
HFU, Campus Schwenningen, Pelobiotech GmbH

Funding program
Baden Württemberg - Ministerium für Wissenschaft Forschung und Kunst

dINA

Digital immuno-isothermal nucleic acid amplification (dINA) assay for high-sensitivity analyzes with a wide dynamic range.

The goal is to use the dINA project to replace existing technologies (ELISA etc.) for the precise quantification of active substances and to establish a new technology platform for highly sensitive analytical methods. Compared to existing methods, it represents a significant system simplification exceeding the current state of the art technologies in terms of precision of quantification as well as speed and cost-effectiveness. Therefore, the aim of this project is to realize and characterize a functional model of a centrifugal processing device, which is suitable for the automated performance of biochemical analyzes based on so-called "digital amplification processes" in emulsion.